Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Paul Ausick | Mar 20, 2014 at 12:10 PM EDT

Akebia, MediWound Post Gains Following IPOs

Mediwound offered 5 million shares in a Thursday IPO at the low end of the expected range. Akebia Therapeutics offered…

Jon C. Ogg | Mar 19, 2014 at 10:10 AM EDT

Are Biotech Stocks Located in Ireland Top Buyout Candidates?

St. Patrick's Day may have come and gone for this year, but the analysts at biotech boutique shop Leerink have…

Paul Ausick | Mar 14, 2014 at 11:10 AM EDT

Castlight Health IPO: The Cloud’s the Limit

Health care software maker Castlight Health launched its initial public offering (IPO) Friday morning, and "launch" is the right word.…

cgblaine22 | Mar 14, 2014 at 11:05 AM EDT

Why Teva May Be Back From the Dead

Two analyst upgrades on Friday, a new CEO and a 33% increase in its stock price since November may be…

Trey Thoelcke | Mar 14, 2014 at 10:30 AM EDT

Ten Top Biotech Merger and Partnership Candidates

In a new research report, the boutique firm Leerink highlights 10 top biotech names that are strong candidates for a…

Trey Thoelcke | Mar 14, 2014 at 8:50 AM EDT

Jefferies’ Cheapest Health Care Stocks to Buy

In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis,…

Douglas A. McIntyre | Mar 14, 2014 at 6:49 AM EDT

Smoking Rate Highest in Kentucky, Lowest in Utah

courtesy of NBN at German WikipediaMore than 30.2% of people in Kentucky were smokers in 2013. Barely behind at 29.9%…

Paul Ausick | Mar 12, 2014 at 2:51 PM EDT

Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent

Wikimedia CommonsShares of drug maker Pfizer Inc. (NYSE: PFE) were halted Wednesday afternoon at $32.29, down about 0.4% from the…

cgblaine22 | Mar 12, 2014 at 11:10 AM EDT

Zogenix Tumbles on Fears Its Pain Drug May Lose Out to a Rival

Shares of Zogenix fell as much as 26% on Wednesday after a rival pharmaceutical company said it will seek regulatory…

Jon C. Ogg | Mar 12, 2014 at 9:45 AM EDT

Back to Normalcy at Geron

Geron is getting a reality check on Wednesday. After a recovery from years of disappointment, this is starting to feel…

Trey Thoelcke | Mar 12, 2014 at 7:10 AM EDT

Short Sellers Retreat From Biotech Stocks Again

Biotech and emerging pharmaceutical stocks continue to be hot, but short sellers shied away from many of them in late…

Trey Thoelcke | Mar 11, 2014 at 8:45 AM EDT

Catalysts That Could Push Top Biotech Stocks Even Higher

Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In…

Trey Thoelcke | Mar 11, 2014 at 7:15 AM EDT

La Jolla Pharmaceutical Shares Surge on Positive Trial Results

La Jolla Pharmaceutical shares surged after the micro-cap biotech said late Monday that its study for a chronic kidney disease…

Thomas Frohlich | Mar 11, 2014 at 6:31 AM EDT

The Fattest States in America

Based on figures from the Gallup-Healthways Well-Being Index, 24/7 Wall St. reviewed the 10 states with the highest obesity rates.…

Paul Ausick | Mar 10, 2014 at 9:45 AM EDT

Health Insurance Satisfaction Slashed by Coverage Issues

ThinkstockMore than 40% of health insurance plan customers were dissatisfied with their plan’s coverage, according to the latest data from…

1 … 291 292 293 294 295 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Akebia, MediWound Post Gains Following IPOs

Are Biotech Stocks Located in Ireland Top Buyout Candidates?

Castlight Health IPO: The Cloud’s the Limit

Why Teva May Be Back From the Dead

Ten Top Biotech Merger and Partnership Candidates

Jefferies’ Cheapest Health Care Stocks to Buy

Smoking Rate Highest in Kentucky, Lowest in Utah

Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent

Zogenix Tumbles on Fears Its Pain Drug May Lose Out to a Rival

Back to Normalcy at Geron

Short Sellers Retreat From Biotech Stocks Again

Catalysts That Could Push Top Biotech Stocks Even Higher

La Jolla Pharmaceutical Shares Surge on Positive Trial Results

The Fattest States in America

Health Insurance Satisfaction Slashed by Coverage Issues

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Apple Might Haven Taken Aim at OpenAI with New Announcement. There’s Only One Problem.

Warren Buffett’s $400 Billion Is Going Nowhere for Now: Here’s Why Berkshire Hathaway Is My Top Pick for the Next 20 Years

Why One AI Giant Is Paying ~2.2X per GPU More Than What Anthropic Pays SpaceX

Retiring at the Coast Comes With a $9,800 Annual Insurance Shock

How a 401(k) Balance Over $1 Million Quietly Pushes 85 Percent of a Couple's Social Security Into the Taxable Zone

Apple Might Haven Taken Aim at OpenAI with New Announcement. There’s Only One Problem.

Warren Buffett’s $400 Billion Is Going Nowhere for Now: Here’s Why Berkshire Hathaway Is My Top Pick for the Next 20 Years

Health and Healthcare Articles

All Health and Healthcare Articles

Akebia, MediWound Post Gains Following IPOs

Are Biotech Stocks Located in Ireland Top Buyout Candidates?

Castlight Health IPO: The Cloud’s the Limit

Why Teva May Be Back From the Dead

Ten Top Biotech Merger and Partnership Candidates

Jefferies’ Cheapest Health Care Stocks to Buy

Smoking Rate Highest in Kentucky, Lowest in Utah

Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent

Zogenix Tumbles on Fears Its Pain Drug May Lose Out to a Rival

Back to Normalcy at Geron

Short Sellers Retreat From Biotech Stocks Again

Catalysts That Could Push Top Biotech Stocks Even Higher

La Jolla Pharmaceutical Shares Surge on Positive Trial Results

The Fattest States in America

Health Insurance Satisfaction Slashed by Coverage Issues

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Apple Might Haven Taken Aim at OpenAI with New Announcement. There’s Only One Problem.

Warren Buffett’s $400 Billion Is Going Nowhere for Now: Here’s Why Berkshire Hathaway Is My Top Pick for the Next 20 Years

Why One AI Giant Is Paying ~2.2X per GPU More Than What Anthropic Pays SpaceX

Featured Reads

Retiring at the Coast Comes With a $9,800 Annual Insurance Shock

How a 401(k) Balance Over $1 Million Quietly Pushes 85 Percent of a Couple's Social Security Into the Taxable Zone